ES2189018T3 - Utilizacion de polvos de polimeros o granulados de polimeros redispersables para el revestimiento de formas de administracion farmaceuticas o agroquimicas. - Google Patents

Utilizacion de polvos de polimeros o granulados de polimeros redispersables para el revestimiento de formas de administracion farmaceuticas o agroquimicas.

Info

Publication number
ES2189018T3
ES2189018T3 ES98103625T ES98103625T ES2189018T3 ES 2189018 T3 ES2189018 T3 ES 2189018T3 ES 98103625 T ES98103625 T ES 98103625T ES 98103625 T ES98103625 T ES 98103625T ES 2189018 T3 ES2189018 T3 ES 2189018T3
Authority
ES
Spain
Prior art keywords
polymer dust
redispersable
agrochemical
pharmaceutical
administration forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98103625T
Other languages
English (en)
Inventor
Karl Kolter
Kristin Tiefensee
Reinhold Stadler
Katrin Zeitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2189018T3 publication Critical patent/ES2189018T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

USO DE POLVOS DE POLIMEROS O GRANULADOS DE POLIMEROS REDISPERSABLES PARA LA COBERTURA DE FORMAS DE ADMINISTRACION FARMACEUTICAS O AGROQUIMICAS, DONDE EL MATERIAL DE COBERTURA CONTIENE A) ENTRE 10 Y 95 % EN PESO DE ACETATO DE POLIVINILO, B) ENTRE 5 Y 90 % EN PESO DE UN POLIMERO QUE CONTIENE N VINILPIRROLIDONA, C) ENTRE 0 Y 20 % EN PESO, DE OTRA SUSTANCIA SOLUBLE EN AGUA O HINCHABLE EN AGUA Y D) ENTRE 0 Y 20 % EN PESO DE UN AGENTE PRODUCTOR DE POLVO INSOLUBLE EN AGUA, ASI COMO OPCIONALMENTE E) OTROS ADITIVOS.
ES98103625T 1997-03-10 1998-03-02 Utilizacion de polvos de polimeros o granulados de polimeros redispersables para el revestimiento de formas de administracion farmaceuticas o agroquimicas. Expired - Lifetime ES2189018T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19709532A DE19709532A1 (de) 1997-03-10 1997-03-10 Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen

Publications (1)

Publication Number Publication Date
ES2189018T3 true ES2189018T3 (es) 2003-07-01

Family

ID=7822670

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98103625T Expired - Lifetime ES2189018T3 (es) 1997-03-10 1998-03-02 Utilizacion de polvos de polimeros o granulados de polimeros redispersables para el revestimiento de formas de administracion farmaceuticas o agroquimicas.

Country Status (11)

Country Link
US (1) US6046277A (es)
EP (1) EP0868912B1 (es)
JP (1) JPH10306041A (es)
AT (1) ATE229327T1 (es)
AU (1) AU5835998A (es)
CA (1) CA2228818A1 (es)
DE (2) DE19709532A1 (es)
DK (1) DK0868912T3 (es)
ES (1) ES2189018T3 (es)
PT (1) PT868912E (es)
SI (1) SI0868912T1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
DE19824650A1 (de) * 1998-05-24 1999-11-25 Bodmeier Roland Redispergierbare Polymerpulver
US7344730B1 (en) 1998-08-05 2008-03-18 Basf Se Soil granulates with controlled active ingredient release (cr soil granulates)
JP2000191407A (ja) * 1998-12-25 2000-07-11 Nissan Chem Ind Ltd 被覆農業用組成物
DE19964153B4 (de) * 1999-03-10 2006-06-01 Wacker Chemie Ag Verwendung von Fällungsmittel-Konzentrat zur Herstellung von schnell trocknenden Putzmassen
IN191482B (es) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
US6730349B2 (en) * 1999-04-19 2004-05-04 Scimed Life Systems, Inc. Mechanical and acoustical suspension coating of medical implants
US6368658B1 (en) 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
DE19961897A1 (de) * 1999-12-20 2001-06-28 Basf Ag Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
DE10029201A1 (de) * 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
CN1193048C (zh) * 2000-09-29 2005-03-16 巴斯福股份公司 聚合物水分散体
KR20040047747A (ko) * 2001-03-13 2004-06-05 펜웨스트 파머슈티칼즈 컴파니 변시치료 제형
DK2258158T3 (en) 2002-02-26 2018-08-06 Compass Minerals Manitoba Inc Seed product with coating of fine powder with plant nutrients and process for their preparation
US20030165614A1 (en) * 2002-03-01 2003-09-04 Henrik Hansen Coating a medical implant using a pan coater
DE10211289A1 (de) 2002-03-14 2003-09-25 Basf Ag Kombination von Polyvinylacetat von wasserunlöslichen, säureunlöslichen oder alkaliunlöslichen Polymeren zur Hestellung von Filmüberzügen mit sehr kontrollierter Freisetzung und hoher Stabilität
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
DE10309064A1 (de) * 2003-03-03 2004-09-16 Clariant Gmbh Polymere Zusammensetzung auf Basis von PVA
EA200600066A1 (ru) * 2003-07-01 2006-06-30 Крка, Товарна Здравил, Д.Д. Ново Место Тамсулозинсодержащее ядро, покрытое поливинилпирролидоном или поливинилацетатом
WO2005027843A2 (en) 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
DE102005042039A1 (de) * 2005-09-02 2007-03-08 Basf Ag Wässrige Polyvinylacetatdispersionen mit hoher Scherstabilität
ATE536867T1 (de) * 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
US8287903B2 (en) 2011-02-15 2012-10-16 Tris Pharma Inc Orally effective methylphenidate extended release powder and aqueous suspension product
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
JP6063726B2 (ja) * 2012-12-03 2017-01-18 花王株式会社 色素顆粒
US10646452B2 (en) 2013-03-15 2020-05-12 New Jersey Institute Of Technology System and method for fabrication of uniform polymer films containing nano and micro particles via continuous drying process
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
EP3238540A1 (en) * 2016-04-28 2017-11-01 Bayer CropScience Aktiengesellschaft Timed-release-type granular agrochemical composition and method for manufacturing same
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition
JP7794661B2 (ja) * 2021-03-05 2026-01-06 三井化学クロップ＆ライフソリューション株式会社 被覆農薬組成物
CN121038779A (zh) 2023-02-03 2025-11-28 特瑞斯制药公司 每晚一次的低钠羟丁酸盐组合物
AU2024425071A1 (en) 2024-02-02 2026-07-30 Tris Pharma, Inc. Liquid clonidine extended release composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1216486B (de) * 1964-04-23 1966-05-12 Merck Ag E Verfahren zur Herstellung von Dragees
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
DE2612889B1 (de) * 1976-03-26 1977-09-01 Basf Ag UEberzugsmittel fuer Arzneiformlinge
US5252704A (en) * 1992-06-05 1993-10-12 Air Products And Chemicals, Inc. Redispersible polymer powders using polyvinyl pyrrolidone as a dispersing aid
DE4220782A1 (de) * 1992-06-25 1994-01-05 Basf Ag Verfahren zur Herstellung von festen pharmazeutischen Retardformen
US5490999A (en) * 1994-04-04 1996-02-13 The Procter & Gamble Company Process for making reduced fat nut spreads
DE19525068A1 (de) * 1995-07-10 1997-01-16 Wacker Chemie Gmbh Beschichtungsmassen auf Basis von in Wasser redispergierbaren, wasserlösliches Polymer und Organosiliciumverbindung enthaltenden Pulvern

Also Published As

Publication number Publication date
DK0868912T3 (da) 2003-01-06
DE59806578D1 (de) 2003-01-23
AU5835998A (en) 1998-09-10
JPH10306041A (ja) 1998-11-17
EP0868912A3 (de) 1999-09-15
PT868912E (pt) 2003-04-30
US6046277A (en) 2000-04-04
EP0868912A2 (de) 1998-10-07
SI0868912T1 (en) 2003-02-28
DE19709532A1 (de) 1998-09-17
EP0868912B1 (de) 2002-12-11
ATE229327T1 (de) 2002-12-15
CA2228818A1 (en) 1998-09-10

Similar Documents

Publication Publication Date Title
ES2126536B1 (es) "preparado farmaceutico para administracion intranasal y procedimientopara su produccion".
ES2010648A4 (es) Formulaciones farmaceuticas de sustancias labiles frente a los acidospara uso oral.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ATE251449T1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
EP0868912A3 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
ES2235311T8 (es) Formulación de budesónida/formoterol para inhalación que tiene una densidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma.
CL2004001191A1 (es) Compuestos derivados de esteroides 17 alpha-fluoroalquilados, con actividad antigestagena; composicion farmaceutica; combinacion farmaceutica; y uso del compuesto en la preparacion de un medicamento antiestrogenico, para el tratamiento de dismenorrea
ATE22007T1 (de) Pharmazeutische mischung.
ATE65023T1 (de) Pharmazeutische mittel.
ES2031491T3 (es) Tableta para uso farmaceutico capaz de liberar sustancias activas en momentos sucesivos.
ATE2616T1 (de) 1-aryl-2-acylamido-3-fluor-1-propanole, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
ATE37028T1 (de) Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte.
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
ES2108258T3 (es) Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo.
DE69828527D1 (de) Polyethylenglycol-matrixpellets für fettige, ölige oder klebrige arzneistoffe
IT1275816B1 (it) Composizioni farmaceutiche solide per uso vaginale
AR242907A1 (es) Dispositivo de doble punta para dosificar y suministrar medicamentos.
ES2145075T3 (es) Nuevos derivados fibrinoliticos de la uroquinasa, plasmidos para su preparacion y tromboliticos que los contienen.
AR002978A1 (es) Compuestos benzamidas, composiciones farmacéuticasque los contienen, metodos para preparar los mismos y el uso de los mismos.
FI922698A0 (fi) Foerbaettrade acetazolamidpreparat.
DE68902811D1 (de) Pharmazeutische zusammensetzungen mit einem gehalt an labdan-di-terpenoid-derivaten und pyrimido(6,1-a)isochinolin-4-on-derivaten und ihre anwendung.
FI821324A0 (fi) Oxazolderivat
DE69703308D1 (de) Lh-rh analoge mit starrer konformation, deren verwendungen und pharmazeutische zusammensetzungen
IT8219586A0 (it) Composti policiclici contenenti un doppio legame nell'anello d,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.